Stay updated with breaking news from Active Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trading in Active Biotech AB paid subscription shares is to cease. The last trading day is September 19, 2022. Short name: ACTI BTA --------------------------- ISIN code: SE0018397895 --------------------------- Orderbook
With effect from August 22, 2022, the subscription rights in Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including August 31, 2022. Instrument: Subscription
/PRNewswire/ -- According to Coherent Market Insights, the global kidney cancer drugs market is estimated to be valued at US$ 5.83 billion in 2022 and is...
NeoTX, whose team includes several Nobel laureates, is testing a cancer-fighting approach that uses bacteria to bait the immune system into an attack.
Investegate announcements from Active Biotech, Annual General Meeting of Active Biotech AB